1. Home
  2. RGNX vs KRUS Comparison

RGNX vs KRUS Comparison

Compare RGNX & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • KRUS
  • Stock Information
  • Founded
  • RGNX 2008
  • KRUS 2008
  • Country
  • RGNX United States
  • KRUS United States
  • Employees
  • RGNX N/A
  • KRUS N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • KRUS Restaurants
  • Sector
  • RGNX Health Care
  • KRUS Consumer Discretionary
  • Exchange
  • RGNX Nasdaq
  • KRUS Nasdaq
  • Market Cap
  • RGNX 661.2M
  • KRUS 673.3M
  • IPO Year
  • RGNX 2015
  • KRUS 2019
  • Fundamental
  • Price
  • RGNX $13.08
  • KRUS $55.89
  • Analyst Decision
  • RGNX Strong Buy
  • KRUS Buy
  • Analyst Count
  • RGNX 7
  • KRUS 8
  • Target Price
  • RGNX $30.00
  • KRUS $93.63
  • AVG Volume (30 Days)
  • RGNX 602.9K
  • KRUS 232.0K
  • Earning Date
  • RGNX 11-06-2025
  • KRUS 11-06-2025
  • Dividend Yield
  • RGNX N/A
  • KRUS N/A
  • EPS Growth
  • RGNX N/A
  • KRUS N/A
  • EPS
  • RGNX N/A
  • KRUS N/A
  • Revenue
  • RGNX $155,782,000.00
  • KRUS $269,327,000.00
  • Revenue This Year
  • RGNX $198.02
  • KRUS $20.55
  • Revenue Next Year
  • RGNX $2.67
  • KRUS $20.07
  • P/E Ratio
  • RGNX N/A
  • KRUS N/A
  • Revenue Growth
  • RGNX 74.95
  • KRUS 18.76
  • 52 Week Low
  • RGNX $5.04
  • KRUS $40.03
  • 52 Week High
  • RGNX $13.93
  • KRUS $110.66
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 57.58
  • KRUS 33.88
  • Support Level
  • RGNX $12.66
  • KRUS $53.80
  • Resistance Level
  • RGNX $13.93
  • KRUS $67.70
  • Average True Range (ATR)
  • RGNX 0.69
  • KRUS 3.54
  • MACD
  • RGNX -0.05
  • KRUS -0.19
  • Stochastic Oscillator
  • RGNX 57.85
  • KRUS 14.75

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.

Share on Social Networks: